GEORGE MURPHY: Open Payments
NPI 1831693795 · PORTLAND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,441 in 56 payments from 13 companies in 2025. Trend: 2023 $1,599 · 2024 $1,336 · 2025 $1,441
Food & beverage: $1,441
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $348 |
| PFIZER INC. | 13 | $319 |
| Novartis Pharmaceuticals Corporation | 11 | $225 |
| BridgeBio Pharma, Inc. | 2 | $113 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $104 |
| Boston Scientific Corporation | 4 | $83 |
| Amgen Inc. | 3 | $81 |
| E.R. Squibb & Sons, L.L.C. | 2 | $46 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $37 |
| Novo Nordisk Inc | 2 | $30 |
Products named: FARXIGA, ELIQUIS, LEQVIO, VYNDAQEL, Attruby, JARDIANCE, REPATHA, WATCHMAN Access System.
Industry payments across OR — which companies pay providers there.
